Laparoscopic magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: systematic review and pooled analysis

被引:43
作者
Guidozzi, Nadia [1 ]
Wiggins, Tom [1 ]
Ahmed, Ahmed R. [1 ]
Hanna, George B. [1 ]
Markar, Sheraz R. [1 ]
机构
[1] Imperial Coll London, Dept Surg & Canc, London, England
关键词
fundoplication; gastroesophageal reflux disease; magnetic sphincter augmentation; NISSEN FUNDOPLICATION; MANAGEMENT-SYSTEM; OUTCOMES; COMPLICATIONS; MULTICENTER; TRIAL;
D O I
10.1093/dote/doz031
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Magnetic sphincter augmentation (MSA) has been proposed as a less invasive, more appealing alternative intervention to fundoplication for the treatment of gastroesophageal reflux disease (GERD). The aim of this study was to evaluate clinical outcomes following MSA for GERD control in comparison with laparoscopic fundoplication. A systematic electronic search for articles was performed in Medline, Embase, Web of Science, and Cochrane Library for single-arm cohort studies or comparative studies (with fundoplication) evaluating the use of MSA. A random-effects meta-analysis for postoperative proton pump inhibitor (PPI) use, GERD-health-related quality of life (GERD-HRQOL), gas bloating, ability to belch, dysphagia, and reoperation was performed. The systematic review identified 6 comparative studies of MSA versus fundoplication and 13 single-cohort studies. Following MSA, only 13.2% required postoperative PPI therapy, 7.8% dilatation, 3.3% device removal or reoperation, and esophageal erosion was seen in 0.3%. There was no significant difference between the groups in requirement for postoperative PPI therapy (pooled odds ratio, POR = 1.08; 95%CI 0.40-2.95), GERD-HRQOL score (weighted mean difference, WMD= 0.34; 95%CI -0.70-1.37), dysphagia (POR = 0.94; 95%CI 0.57-1.55), and reoperation (POR = 1.23; 95%CI 0.26-5.8). However, when compared to fundoplicationMSA was associated with significantly less gas bloating (POR = 0.34; 95%CI 0.16-0.71) and a greater ability to belch (POR = 12.34; 95%CI 6.43-23.7). In conclusion, magnetic sphincter augmentation achieves good GERD symptomatic control similar to that of fundoplication, with the benefit of less gas bloating. The safety of MSA also appears acceptable with only 3.3% of patients requiring device removal. There is an urgent need for randomized data directly comparing fundoplication with MSA for the treatment of GERD to truly evaluate the efficacy of this treatment approach.
引用
收藏
页数:8
相关论文
共 38 条
[1]   Early results of magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: Systematic review and meta-analysis [J].
Aiolfi, Alberto ;
Asti, Emanuele ;
Bernardi, Daniele ;
Bonitta, Gianluca ;
Rausa, Emanuele ;
Siboni, Stefano ;
Bonavina, Luigi .
INTERNATIONAL JOURNAL OF SURGERY, 2018, 52 :82-88
[2]   Worldwide Experience with Erosion of the Magnetic Sphincter Augmentation Device [J].
Alicuben, Evan T. ;
Bell, Reginald C. W. ;
Jobe, Blair A. ;
Buckley, F. P., III ;
Smith, C. Daniel ;
Graybeal, Casey J. ;
Lipham, John C. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (08) :1442-1447
[3]   Longitudinal comparison of quality of life in patients undergoing laparoscopic Toupet fundoplication versus magnetic sphincter augmentation Observational cohort study with propensity score analysis [J].
Asti, Emanuele ;
Bonitta, Gianluca ;
Lovece, Andrea ;
Lazzari, Veronica ;
Bonavina, Luigi .
MEDICINE, 2016, 95 (30)
[4]   Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial [J].
Bell, Reginald ;
Lipham, John ;
Louie, Brian ;
Williams, Valerie ;
Luketich, James ;
Hill, Michael ;
Richards, William ;
Dunst, Christy ;
Lister, Dan ;
McDowell-Jacobs, Lauren ;
Reardon, Patrick ;
Woods, Karen ;
Gould, Jon ;
Buckley, F. Paul, III ;
Kothari, Shanu ;
Khaitan, Leena ;
Smith, C. Daniel ;
Park, Adrian ;
Smith, Christopher ;
Jacobsen, Garth ;
Abbas, Ghulam ;
Katz, Philip .
GASTROINTESTINAL ENDOSCOPY, 2019, 89 (01) :14-+
[5]   One Hundred Consecutive Patients Treated with Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease: 6 Years of Clinical Experience from a Single Center [J].
Bonavina, Luigi ;
Saino, Greta ;
Bona, Davide ;
Sironi, Andrea ;
Lazzari, Veronica .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (04) :577-585
[6]   LINX® Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux [J].
Bonavina, Luigi ;
Saino, Greta ;
Lipham, John C. ;
DeMeester, Tom R. .
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2013, 6 (04) :261-268
[7]   Magnetic Augmentation of the Lower Esophageal Sphincter: Results of a Feasibility Clinical Trial [J].
Bonavina, Luigi ;
Saino, Greta I. ;
Bona, Davide ;
Lipham, John ;
Ganz, Robert A. ;
Dunn, Daniel ;
DeMeester, Tom .
JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (12) :2133-2140
[8]   Favorable results from a prospective evaluation of 200 patients with large hiatal hernias undergoing LINX magnetic sphincter augmentation [J].
Buckley, F. P., III ;
Bell, Reginald C. W. ;
Freeman, Kate ;
Doggett, Stephanie ;
Heidrick, Rachel .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2018, 32 (04) :1762-1768
[9]   Outcomes of magnetic sphincter augmentation - A community hospital perspective [J].
Czosnyka, Nicholas M. ;
Buckley, F. Paul ;
Doggett, Stephanie L. ;
Vassaur, Hannah ;
Connolly, Erin E. ;
Borgert, Andrew J. ;
Kallies, Kara J. ;
Kothari, Shanu N. .
AMERICAN JOURNAL OF SURGERY, 2017, 213 (06) :1019-1023
[10]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188